Maximal and submaximal aerobic fitness in postmenopausal women: influence of hormone-replacement therapy

被引:4
|
作者
Stathokostas, Liza [1 ]
Kowalchuk, John M. [1 ]
Petrella, Robert J. [2 ]
Paterson, Donald H. [1 ]
机构
[1] Univ Western Ontario, Sch Kinesiol, Canadian Ctr Act & Aging, London, ON N6A 3K7, Canada
[2] Univ Western Ontario, Sch Med & Dent, Canadian Ctr Act & Aging, London, ON N6A 3K7, Canada
关键词
maximal oxygen uptake; ventilatory threshold; cycle ergometer exercise; aging; hormone status;
D O I
10.1139/H08-070
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The purpose of this study was to examine whether maximal and submaximal aerobic fitness parameters ( peak oxygen consumption and ventilatory threshold, respectively) are affected by hormone-replacement therapy (HRT) in moderately active postmenopausal women. Forty healthy, active, postmenopausal women ( 21 taking HRT, mean age 62 +/- 5 years; 19 not taking HRT, mean age 62 +/- 7 years) met the peak oxygen consumption criteria during a cycle ergometer test ( 15 W ramp) and achieved volitional fatigue. Breath-by-breath measurement was used to determine peak oxygen consumption and to estimate ventilatory threshold. There were no differences in characteristics ( age, body mass, height, body mass index, leisure-time physical activity) between the non-HRT and HRT groups, nor were there any differences in responses to maximal exercise, with an observed peak oxygen consumption (mL.kg(-1) min(-1)) of 22.9 +/- 3.8 in the non-HRT group and 22.0 +/- 4.7 in the HRT group. There was also no difference in submaximal aerobic capacity, with ventilatory threshold values (mL.kg(-1) min(-1)) of 16.7 +/- 3.4 in the non-HRT group and 15.6 +/- 3.2 in the HRT group. In a sample of healthy moderately active postmenopausal women, there was no difference in maximal or submaximal aerobic fitness parameters beteen the HRT and non-HRT groups.
引用
收藏
页码:922 / 928
页数:7
相关论文
共 50 条
  • [1] POSTMENOPAUSAL HORMONE-REPLACEMENT THERAPY
    MARTIN, KA
    FREEMAN, MW
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (15): : 1115 - 1117
  • [2] Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
    Koh, KK
    Mincemoyer, R
    Bui, MN
    Csako, G
    Pucino, F
    Guetta, V
    Waclawiw, M
    Cannon, RO
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (10): : 683 - 690
  • [3] Postmenopausal hormone-replacement therapy
    Lam, J
    REVISTA MEDICA DE CHILE, 2001, 129 (11) : 1351 - 1352
  • [4] Hormone-replacement therapy compared with simvastatin for postmenopausal women with hypercholesterolemia
    Cashin-Hemphill, L
    Vailas, LI
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (01): : 63 - 63
  • [5] Postmenopausal hormone-replacement therapy - Reply
    Manson, JE
    Martin, KA
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (01): : 65 - 65
  • [6] Postmenopausal hormone-replacement therapy.
    Manson, JE
    Martin, KA
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01): : 34 - U6
  • [7] Uterine and cerebral vascularization in postmenopausal women treated with hormone-replacement therapy
    Battaglia, C
    Regnani, G
    Artini, PG
    Genazzani, AR
    Primavera, MR
    Salvatori, M
    Volpe, A
    GYNECOLOGICAL ENDOCRINOLOGY, 1999, 13 (04) : 223 - 229
  • [8] Does hormone-replacement therapy prevent fractures in early postmenopausal women?
    Randell, KM
    Honkanen, RJ
    Kröger, H
    Saarikoski, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (03) : 528 - 533
  • [9] Effects of hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women
    Mussoni, C
    Fiorito, A
    Grippo, MC
    Martini, C
    Panourgia, MP
    Galetti, C
    Dormi, A
    Gaddi, A
    ATHEROSCLEROSIS, 1999, 144 : 98 - 99
  • [10] POSTMENOPAUSAL HORMONE-REPLACEMENT THERAPY AND CARDIOVASCULAR RISK
    KREMPLER, F
    SOYAL, SM
    PATSCH, W
    ANNALS OF MEDICINE, 1995, 27 (02) : 149 - 156